Olfaction is an essential chemosensory system in the living world. Although less appreciated in humans, smell impairment significantly affects many aspects of quality of life. Smell disorders may be caused by an impaired nasal airway or by lesions in the olfactory system, leading to reduced or distorted smell perception. The most common causes of smell disorders are aging, upper respiratory tract infection, sinonasal disease, and head trauma. Recovery is rarely complete. Counseling is important in progressive or severe smell loss. In patients with distorted smell perception, antidepressant medication is sometimes necessary. Best response to treatment is achieved for nasal obstruction and sinonasal inflammatory disease. Treatment of olfactory impairment caused by sinonasal disease includes medication with topical and systemic steroids, or surgery for refractory cases. Although there are reports that surgical resection of olfactory neurons may lead to reinnervation and recovery of smell, adequate treatment of the smell loss remains an unmet need.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Oka Y, Korsching SI. Shared and unique G alpha proteins in the zebrafish versus mammalian senses of taste and smell. Chem Senses. 2011;36:357–65.
Nijland R, Burgess JG. Bacterial olfaction. Biotechnol J. 2010;5:974–7.
Rowe TB, Macrini TE, Luo ZX. Fossil evidence on origin of the mammalian brain. Science. 2011;332:955–7.
Gagliardo A, Filannino C, Ioalè P, et al. Olfactory lateralization in homing pigeons: a GPS study on birds released with unilateral olfactory inputs. J Exp Biol. 2011;214:593–8.
Ueda H. Physiological mechanism of homing migration in Pacific salmon from behavioral to molecular biological approaches. Gen Comp Endocrinol. 2011;170:222–32.
Stowers L, Logan DW. Sexual dimorphism in olfactory signaling. Curr Opin Neurobiol. 2010;20:770–5.
Doty RL. The olfactory system and its disorders. Semin Neurol. 2009;29:74–81.
Croy I, Olgun S, Joraschky P. Basic emotions elicited by odors and pictures. Emotion. 2011;11:1331–5.
Chopard G, Galmiche J, Jacquot L, Brand G. Just noticeable difference in olfaction: a discriminative tool between healthy elderly and patients with cognitive disorders associated with dementia. Rhinology. 2011;49:513–8.
Gopinath B, Anstey KJ, Sue CM, Kifley A, Mitchell P. Olfactory impairment in older adults is associated with depressive symptoms and poorer quality of life scores. Am J Geriatr Psychiatry. 2011;19:830–4.
DeMaria S, Ngai J. The cell biology of smell. J Cell Biol. 2010;191:443–52.
Leopold DA, Hummel T, Schwob JE, et al. Anterior distribution of human olfactory epithelium. Laryngoscope. 2000;110:417–21.
Ienkins PM, McEwen DP, Martens JR. Olfactory cilia: linking sensory cilia function and human disease. Chem Senses. 2009;34:451–64.
Buck L, Axel R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell. 1991;65:175–87.
Malnic B, Hirono J, Sato T, Buck LB. Combinatorial receptor codes for odors. Cell. 1999;96:713–23.
• Baraniuk JN, Merck SJ. New concepts of neural regulation in human nasal mucosa. Acta Clin Croat. 2009;48:65–73. This is an excellent review on nasal physiology and function of TRP proteins in the respiratory system and sensing environment.
Murthy VN. Olfactory maps in the brain. Annu Rev Neurosci. 2011;34:233–58.
Pain F, L’heureux B, Gurden H. Visualizing odor representation in the brain: a review of imaging techniques for the mapping of sensory activity in the olfactory glomeruli. Cell Mol Life Sci. 2011;68:2689–709.
Cleland TA, Linster C. Computation in the olfactory system. Chem Senses. 2005;30:801–13.
Doty RL, Shaman P, Applebaum SL, et al. Smell identification ability: changes with age. Science. 1984;226:1441–3.
Murphy C, Schubert CR, Cruickshanks KJ, et al. Prevalence of olfactory impairment in older adults. JAMA. 2002;288:2307–12.
Brämerson A, Johansson L, Ek L, Nordin S, Bende M. Prevalence of olfactory dysfunction: the Skövde population-based study. Laryngoscope. 2004;114:733–7.
• Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Olfactory impairment in older adults: five-year incidence and risk factors. Laryngoscope. 2011;121:873–8. This is a recent study evaluating risk factors for olfactory impairment and indicating some protective measures in the older adult population.
•• Litvack JR, Mace JC, Smith TL. Olfactory function and disease severity in chronic rhinosinusitis. Am J Rhinol Allergy. 2009;23:139–44. This is an important multicenter study of the relationship between severity of CRS measured by different subjective and objective tools and olfactory impairment in the population of surgical (more severe) patients; it also provides insight on the impact of dysosmia on quality of life in this subgroup of patients.
•• Neuland C, Bitter T, Marschner H, Gudziol H, Guntinas-Lichius O. Health-related and specific olfaction-related quality of life in patients with chronic functional anosmia or severe hyposmia. Laryngoscope. 2011;121:867–72. This is an important study in a big group of patients with different risk factors and phenotypes. It provides analysis of the impact of smell disorders on quality of life on a generic and olfaction-specific questionnaire, recognizing more vulnerable subgroups.
• Rombaux P, Duprez T, Hummel T. Olfactory bulb volume in the clinical assessment of olfactory dysfunction. Rhinology. 2009;47:3–9. This review paper points out some of the objective tools to explain the symptoms and severity of smell dysfunction.
•• Scadding G, Hellings P, Alobid I, et al. Diagnostic tools in rhinology. Clinical and Translational Allergy 2011, 1:2:1–39. http://www.ctajournal.com/content/1/1/2. This is a comprehensive review paper analyzing advantages and disadvantages of all available smell tests.
Robinson AM, Conley DB, Shinners MJ, Kern RC. Apoptosis in the aging olfactory epithelium. Laryngoscope. 2002;112:1431–5.
Conley DB, Robinson AM, Shinners MJ, Kern RC. Age-related olfactory dysfunction: cellular and molecular characterization in the rat. Am J Rhinol. 2003;17:169–75.
Schiffman SS. Taste and smell losses in normal aging and disease. JAMA. 1997;278:1357–62.
Meisami E, Mikhail L, Baim D, Bhatnagar KP. Human olfactory bulb: aging of glomeruli and mitral cells and a search for the accessory olfactory bulb. Ann N Y Acad Sci. 1998;855:708–15.
Kalmey JK, Thewissen JG, Dluzen DE. Age-related size reduction of foramina in the cribriform plate. Anat Rec. 1998;251:326–9.
• Wehling E, Nordin S, Espeseth T, Reinvang I, Lundervold AJ. Unawareness of olfactory dysfunction and its association with cognitive functioning in middle aged and old adults. Arch Clin Neuropsychol. 2011;26:260–9. This is a study showing the interaction between the sensory and cognitive systems in middle-aged and older patients, including awareness of olfactory dysfunction.
Croy I, Landis BN, Meusel T, et al. Patient adjustment to reduced olfactory function. Arch Otolaryngol Head Neck Surg. 2011;137:377–82.
Deems DA, Doty RL, Settle RG, et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg. 1991;117:519–28.
Reden J, Mueller A, Mueller C, Konstantinidis I, Frasnelli, et al. Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Arch Otolaryngol Head Neck Surg. 2006;132:265–9.
Fokkens W, Lund V, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps. Rhinology. 2007;Suppl 20:1–136.
Akerlund A, Bende M, Murphy C. Olfactory threshold and nasal mucosal changes in experimentally induced common cold. Acta Otolaryngol. 1995;115:88–92.
Kern RC. Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa. Laryngoscope. 2000;110:1071–7.
Doty RL, Mishra A. Olfaction and its alteration by nasal obstruction, rhinitis, and rhinosinusitis. Laryngoscope. 2001;111:409–23.
Litvack JR, Fong K, Mace J, James KE, Smith TL. Predictors of olfactory dysfunction in patients with chronic rhinosinusitis. Laryngoscope. 2008;118:2225–30.
Vento SI, Simola M, Ertama LO, Malmberg CH. Sense of smell in long-standing nasal polyposis. Am J Rhinol. 2001;15:159–63.
Nordin S, Bramerson A. Complaints of olfactory disorders: epidemiology, assessment and clinical implications. Curr Opin Allergy Clin Immunol. 2008;8:10–5.
Raviv JR, Kern RC. Chronic sinusitis and olfactory dysfunction. Otolaryngol Clin North Am. 2004;37:1143–57.
Konstantinidis I, Triaridis S, Printza A, Vital, et al. Olfactory dysfunction in nasal polyposis: correlation with computed tomography findings. ORL J Otorhinolaryngol Relat Spec. 2007;69:226–32.
Konstantinidis I, Witt M, Kaidoglu K, Constantinidis J, Gudziol V. Olfactory mucosa in nasal polyposis: implications for FESS outcome. Rhinology. 2010;48:47–53.
Bhutta MF, Al-Shaikh S, Latif M, Lee R, Uraiby J. Nasal polyps do not contain olfactory structure. Rhinology. 2011;49:185–9.
Mygind N, Lund V. Intranasal corticosteroids for nasal polyposis: biological rationale, efficacy, and safety. Treat Respir Med. 2006;5:93–102.
Jafek BW, Moran DT, Eller PM, Rowley 3rd JC, Jafek TB. Steroid-dependent anosmia. Arch Otolaryngol Head Neck Surg. 1987;113:547–9.
•• Martinez-Devesa P, Patiar S. Oral steroids for nasal polyps. Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.: CD005232. doi:10.1002/14651858.CD005232.pub3. This is an important meta-analysis of treatment of NP with steroids, including outcomes with regard to olfaction.
• Vaidyanathan S, Barnes M, Williamson P, et al. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids. Ann Intern Med. 2011;154:293–302. This study suggests a combined treatment modality for long-term control of NP.
Jankowski R, Bodino C. Olfaction in patients with nasal polyposis: effects of systemic steroids and radical ethmoidectomy with middle turbinate resection (nasalization). Rhinology. 2003;41:220–30.
Perry BF, Kountakis SE. Subjective improvement of olfactory function after endoscopic sinus surgery for chronic rhinosinusitis. Am J Otolaryngol. 2003;24:366–9.
• Olsson P, Stjarne P. Endoscopic sinus surgery improves olfaction in nasal polyposis, a multi-center study. Rhinology. 2010;48:150–5. This was an uncontrolled trial using several objective tests for olfactory function in patients and comparing pre- and postsurgical smell outcomes.
Bonfils P. Evaluation of the combined medical and surgical treatment in nasal polyposis. I: Functional results. Acta Otolaryngol. 2007;127:436–46.
Bonfils P, Malinvaud D, Soudry Y, Devars du Maine M, Laccourreye O. Surgical therapy and olfactory function. B-ENT. 2009;5 Suppl 13:77–87.
Simmen D, Briner HR. Olfaction in rhinology—methods of assessing the sense of smell. Rhinology. 2006;44:98–101.
Joe SA, Thakkar K. Chronic rhinosinusitis and asthma. Otolaryngol Clin North Am. 2008;41:297–309.
• Cardelus S, Benitez P, Guilemany JM, et al. Persistent asthma has an accumulative impact on the loss of smell in patients with nasal polyposis. Rhinology. 2011;49:519–24. This study indicates that CRS patients with NP are a distinct subgroup of patients also with regard to smell outcomes.
Doty RL, Yousem DM, Pham LT, et al. Olfactory dysfunction in patients with head trauma. Arch Neurol. 1997;54:1131–40.
Yousem DM, Geckle RJ, Bilker WB, et al. Post-traumatic olfactory dysfunction: MR and clinical evaluation. Am J Neuroradiol. 1996;17:1171–9.
• Hummel T, Lötsch J. Prognostic factors of olfactory dysfunction. Arch Otolaryngol Head Neck Surg. 2010;136:347–51. This was a large epidemiologic study evaluating prognosis for smell improvement and analyzing different risk factors in a wide range of patients analyzed with extensive subjective and objective tests.
Wolfensberger M, Schnieper I, Welge-Lüssen A. “Sniffin’ Sticks”: a new olfactory test battery. Acta Otolaryngol. 2000;120:303–6.
London B, Nabet B, Fisher AR, et al. Predictors of prognosis in patients with olfactory disturbance. Ann Neurol. 2008;63:159–66.
Tuccori M, Lapi F, Testi A, et al. Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting. Drug Saf. 2011;34:849–59.
•• Snidvongs K, Kalish L, Sacks R, et al. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database Syst Rev. 2011;8:CD009274. This is a meta-analysis of the most common and only available evidence-based treatment for smell impairment in patients with CRS.
Joe SA, Thambi R, Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2008;139:340–7.
Videler WJ, Badia L, Harvey RJ, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy. 2011;66:1457–68.
Reden J, Herting B, Lill K, et al. Treatment of postinfectious olfactory disorders with minocycline: a double-blind, placebo-controlled study. Laryngoscope. 2011;121:679–82.
Leopold D. Distortion of olfactory perception: diagnosis and treatment. Chem Senses. 2002;27:611–5.
Manestar D, Ticac R, Velepic M, et al. The significance of rhinomanometry in evaluation of postlaryngectomy olfactory rehabilitation by polite yawning technique. Rhinology. 2011;49:238–42.
• Hummel T, Rissom K, Reden J, et al. Effects of olfactory training in patients with olfactory loss. Laryngoscope. 2009;119:496–9. This study is important as it indicates that olfactory training may lead to improvement even without the success of medical treatment.
Frye RE, Schwartz BS, Doty RL. Dose-related effects of cigarette smoking on olfactory function. JAMA. 1990;263:1233–6.
Kimmelman CP. The risk to olfaction from nasal surgery. Laryngoscope. 1994;104:981–8.
Seo BS, Lee HJ, Mo JH, et al. Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray. Arch Otolaryngol Head Neck Surg. 2009;135:1000–4.
Damm M, Temmel A, Welge-Lüssen A, et al. Olfactory dysfunctions. Epidemiology and therapy in Germany, Austria and Switzerland. HNO. 2004;52:112–20.
• Davidson TM, Smith WM. The Bradford Hill criteria and zinc-induced anosmia: a causality analysis. Arch Otolaryngol Head Neck Surg. 2010;136:673–876. This was an important evidence-based analysis of papers indicating the effect of zinc treatment on sense of smell (this is still an actual treatment for the common cold).
No potential conflicts of interest relevant to this article were reported.
About this article
Cite this article
Kalogjera, L., Dzepina, D. Management of Smell Dysfunction. Curr Allergy Asthma Rep 12, 154–162 (2012). https://doi.org/10.1007/s11882-012-0248-5
- Smell dysfunction
- Olfactory receptor
- Nasal obstruction
- Nasal polyps
- Topical steroids
- Oral steroid
- Smell test
- Olfactory nerve
- Olfactory bulb
- Sinus surgery
- Nasal steroids
- Quality of life